Similar articles

• JMM Profile: Trichosporon yeasts: from superficial pathogen to threat for haematological-neutropenic patients.

  Francisco EC, Hagen F. Francisco EC, et al. J Med Microbiol. 2022 Dec;71(12). doi: 10.1099/jmm.0.001621. J Med Microbiol. 2022. PMID: 36748684 Review.
• Insight into the antifungals used to address human infection due to Trichosporon spp.: a scoping review.

  Malacrida AM, Salci TP, Negri M, Svidzinski TI. Malacrida AM, et al. Future Microbiol. 2021 Nov;16:1277-1288. doi: 10.2217/fmb-2021-0048. Epub 2021 Oct 25. Future Microbiol. 2021. PMID: 34689610 Free PMC article. Review.
• Epidemiology and Antifungal Susceptibility of Infections Caused by Trichosporon Species: An Emerging Non-Candida and Non-Cryptococcus Yeast Worldwide.

  Singh S, Capoor MR, Varshney S, Gupta DK, Verma PK, Ramesh V. Singh S, et al. Indian J Med Microbiol. 2019 Oct-Dec;37(4):536-541. doi: 10.4103/ijmm.IJMM_19_146. Indian J Med Microbiol. 2019. PMID: 32436877
• Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature.

  Milan EP, Silva-Rocha WP, de Almeida JJS, Fernandes TUG, de Araújo Prudente AL, de Azevedo MF, Francisco EC, de Azevedo Melo AS, Colombo AL, Chaves GM. Milan EP, et al. BMC Infect Dis. 2018 Sep 18;18(1):470. doi: 10.1186/s12879-018-3363-7. BMC Infect Dis. 2018. PMID: 30227852 Free PMC article. Review.
• Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

  Treviño M, García-Riestra C, Areses P, García X, Navarro D, Suárez FJ, López-Dequidt IA, Zaragoza O, Cuenca-Estrella M. Treviño M, et al. Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1497-503. doi: 10.1007/s10096-014-2099-6. Epub 2014 Apr 10. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24718613